These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3259909)

  • 21. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal.
    Borgia M; Longo A; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections.
    de Jong Z; Pontonnier F; Plante P
    Urol Int; 1991; 46(4):344-8. PubMed ID: 1926651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility testing procedures for fosfomycin tromethamine.
    Barry AL; Fuchs PC
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1235-8. PubMed ID: 1929270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of acute cystitis in women. Single-dose versus a 3-day and 10-day therapeutic regimen with with trimethoprim-sulfamethoxazole].
    Gossius G; Vorland L
    Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1395-8. PubMed ID: 3529490
    [No Abstract]   [Full Text] [Related]  

  • 29. The carriage of Escherichia coli on the peri-urethral area and in the feces in patients on long term low dose cotrimoxazole therapy.
    Cattell WR; McSherry MA; Brooks HL; O'Grady FW
    Clin Nephrol; 1976 Dec; 6(6):506-8. PubMed ID: 795583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice.
    Boerema JB; Willems FT
    Infection; 1990; 18 Suppl 2():S80-8. PubMed ID: 2286467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism between trimethoprim and sulfonamide in urine: does it exist?
    Watson ID; Cohen HN; McIntosh SJ; Thomson JA; Shenkin A
    Clin Ther; 1981; 4(2):103-8. PubMed ID: 6975168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections].
    Cortés R; Pascual T; Lou Arnal S; Orozco F; Sunyer L
    Aten Primaria; 1992 Dec; 10(9):1007-12. PubMed ID: 1467416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
    Del Favero A; Frongillo RF; Menichetti F; Boldrini F; Guerciolini R; Pauluzzi S
    Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis.
    Greenwood D
    Infection; 1986; 14(4):186-9. PubMed ID: 3531023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of the combined preparation trimezol--Farmakhim. 1. Plasma levels and urinary excretion of trimethoprim and sulfamethoxazole in the rat].
    Mikhailova D; Mikhaĭlova T; Bogoslovova T; Raĭnova L; Staneva D
    Eksp Med Morfol; 1983; 22(4):23-8. PubMed ID: 6609062
    [No Abstract]   [Full Text] [Related]  

  • 39. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.
    Greenwood D; Edwards R; Brown J; Ridout P
    Infection; 1992; 20 Suppl 4():S302-4. PubMed ID: 1294522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
    Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
    Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.